During the past decade, Weisberg Cancer Treatment Center conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 63 clinical trials were completed, i.e. on average, 44.7% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 50 clinical trials were completed. i.e. 106.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Weisberg Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "NRG Oncology" with 15 trials sponsored, "Pfizer" with 15 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Weisberg Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 81 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Weisberg Cancer Treatment Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Fallopian Tube Carcinoma" (7 trials) and "Recurrent Primary Peritoneal Carcinoma" (7 trials). Many other conditions were trialed in "Weisberg Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "Weisberg Cancer Treatment Center" are "Drug" (156 trials), "Other" (98 trials), "Biological" (59 trials), "Procedure" (52 trials) and "Radiation" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (39 trials), "Computed Tomography" (26 trials), "Biospecimen Collection" (25 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.

The vast majority of trials in "Weisberg Cancer Treatment Center" are 130 trials for "All" genders, 37 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Weisberg Cancer Treatment Center". undefined are not yet recruiting, 41 are recruiting, 90 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Weisberg Cancer Treatment Center, 5 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Weisberg Cancer Treatment Center, 20 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".